For University of Wisconsin–Madison students like Naureen Kamal and Mariam Siddiqui, conducting undergraduate research in the summer offers an important — and sometimes personal — avenue for discovery.
Welcome
The Wisconsin Alzheimer’s Disease Research Center supports researchers in their pursuit of answers that will lead to improved diagnosis and care for patients while, at the same time, focusing on the program’s long-term goal — finding a way to prevent and effectively treat Alzheimer’s disease.
Recent News
Image
Nathaniel Chin, MD, medical director and Clinical Core co-leader of the Wisconsin Alzheimer’s Disease Research Center (ADRC), was one of three experts featured in a recent USA Today article for the health and wellness column.
Image
Henrik Zetterberg, MD, PhD, and Hartmuth Kolb, PhD, have joined the UW School of Medicine and Public Health to study biomarkers in blood and spinal fluid that could help predict a person’s future risk of dementia.
Image
More than 300 people attended the event, which took place on April 22, 2025, at the Discovery Building on the UW–Madison campus.
Image
“It’s really because of the great Wisconsin participants that we now have something that’s pretty revolutionary,” Chin said to reporters.
Image
In an advancement for Alzheimer’s disease diagnosis, the U.S. Food and Drug Administration (FDA) recently granted clearance for an Alzheimer’s disease blood test. Data samples used to evaluate the validity of the test are from research conducted at the University of Wisconsin–Madison.
No front page content has been created yet.
Follow the User Guide to start building your site.
Follow the User Guide to start building your site.
